文献速递腹部MR

定量T1 mapping评估肝纤维化与肝硬化:急性炎症、年龄和肝脏体积是否为混杂因素?

Evaluation of liver fibrosis and cirrhosis on the basis of quantitative T1 mapping: Are acute inflammation, age and liver volume confounding factors?
PubMed 文献 · Eur J Radiol · 2021-05-23

该回顾性研究纳入200例腹部MRI患者,评估T1 mapping定量评估肝纤维化/肝硬化的潜在混杂因素。健康者T1值显著低于急性肝病或已知纤维化/肝硬化患者,T1值与Child-Pugh分期中度相关。急性肝病是混杂因素,年龄不是,可定义年龄无关阈值。

要点

  • 急性肝病会升高T1值,使用T1阈值筛查纤维化/肝硬化前应排除急性炎症。
  • 年龄不是T1值的混杂因素,可采用年龄无关的T1阈值。
  • T1值与Child-Pugh分期中度相关(1.5T,ρ=0.35),可辅助评估肝硬化严重程度。

核心结论

  • T1 mapping是检测肝纤维化和肝硬化的有效预测工具,但急性肝病是混杂因素,年龄不是。

研究设计与样本

  • 回顾性研究,基于2018年7月至2019年4月本院放射信息系统数据库搜索腹部MRI,排除后纳入200例患者(59±16岁)。
  • 93例为肝脏健康者,40例无已知纤维化或肝硬化,67例有临床或活检证实的肝纤维化或肝硬化。
  • 采用基于切片的look-locker方法进行T1 mapping,对左、右肝进行ROI分析,评估脂肪分数、R2*、肝脏体积、实验室参数、性别和年龄作为潜在混杂因素。

诊断标准与关键数值

  • 健康无已知纤维化者T1值:1.5T MRI为575±56 ms,3T MRI为857±128 ms。
  • 急性肝病患者T1值:1.5T MRI为657±73 ms(p<0.0001 vs 健康),3T MRI为952±37 ms(p=0.028 vs 健康)。
  • 已知纤维化或肝硬化患者T1值:1.5T MRI为644±83 ms(p<0.0001 vs 健康),3T MRI为995±150 ms(p=0.018 vs 健康)。
  • T1值与Child-Pugh分期在1.5T时中度相关(p=0.01,ρ=0.35)。

临床应用与阅片要点

  • 使用T1 mapping筛查肝纤维化或肝硬化前,应排除急性肝病,以免T1值假性升高。
  • 年龄不影响T1值,可应用年龄无关的T1阈值,简化临床判读。
  • T1值可作为肝纤维化/肝硬化的预测指标,并与Child-Pugh分期相关,辅助评估病情。

局限性

  • 回顾性研究,单中心,样本量有限,可能存在选择偏倚。
  • 原文未报告敏感度、特异度、AUC等诊断效能指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate potential confounding factors in the quantitative assessment of liver fibrosis and cirrhosis using T1 relaxation times.

METHODS: The study population is based on a radiology-information-system database search for abdominal MRI performed from July 2018 to April 2019 at our institution. After applying exclusion criteria 200 (59 ± 16 yrs) remaining patients were retrospectively included. 93 patients were defined as liver-healthy, 40 patients without known fibrosis or cirrhosis, and 67 subjects had a clinically or biopsy-proven liver fibrosis or cirrhosis. T1 mapping was performed using a slice based look-locker approach. A ROI based analysis of the left and the right liver was performed. Fat fraction, R2*, liver volume, laboratory parameters, sex, and age were evaluated as potential confounding factors.

RESULTS: T1 values were significantly lower in healthy subjects without known fibrotic changes (1.5 T MRI: 575 ± 56 ms; 3 T MRI: 857 ± 128 ms) compared to patients with acute liver disease (1.5 T MRI: 657 ± 73 ms, p < 0.0001; 3 T MRI: 952 ± 37 ms, p = 0.028) or known fibrosis or cirrhosis (1.5 T MRI: 644 ± 83 ms, p < 0.0001; 3 T MRI: 995 ± 150 ms, p = 0.018). T1 values correlated moderately with the Child-Pugh stage at 1.5 T (p = 0.01, ρ = 0.35).

CONCLUSION: T1 mapping is a capable predictor for detection of liver fibrosis and cirrhosis. Especially age is not a confounding factor and, hence, age-independent thresholds can be defined. Acute liver diseases are confounding factors and should be ruled out before employing T1-relaxometry based thresholds to screen for patients with liver fibrosis or cirrhosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Breit HC, Block KT, Winkel DJ, et al. Evaluation of liver fibrosis and cirrhosis on the basis of quantitative T1 mapping: Are acute inflammation, age and liver volume confounding factors? Eur J Radiol. 2021. PMID: 34051684. doi:10.1016/j.ejrad.2021.109789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。